KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $89,415,000 | -8.6% | 1,994,083 | +13.9% | 0.02% | -20.0% |
| Q3 2016 | $97,823,000 | +18.1% | 1,751,216 | +5.7% | 0.02% | +11.1% |
| Q2 2016 | $82,840,000 | +19.6% | 1,656,795 | +9.9% | 0.02% | +12.5% |
| Q1 2016 | $69,242,000 | -14.6% | 1,508,215 | +14.6% | 0.02% | -15.8% |
| Q4 2015 | $81,074,000 | +8.0% | 1,315,703 | -2.4% | 0.02% | 0.0% |
| Q3 2015 | $75,081,000 | -1.3% | 1,348,437 | +8.1% | 0.02% | +5.6% |
| Q2 2015 | $76,038,000 | +83.0% | 1,247,132 | +73.1% | 0.02% | +80.0% |
| Q1 2015 | $41,562,000 | +4.9% | 720,562 | +4.9% | 0.01% | 0.0% |
| Q4 2014 | $39,623,000 | +625.2% | 687,063 | +258.4% | 0.01% | +400.0% |
| Q3 2014 | $5,464,000 | – | 191,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |